Lv2
200 积分 2023-04-19 加入
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
15天前
已完结
Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management
27天前
已完结
Preventive Treatment of Migraine
1个月前
已完结
The pipeline and market for psoriasis drugs
1个月前
已完结
Diagnosis and Management of Headache
2个月前
已完结
The pipeline and market for migraine drugs
2个月前
已完结
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
4个月前
已完结
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
5个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
7个月前
已完结
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
7个月前
已完结
皖公网安备34019202002308
